Why it matters now
The implementation of the European Medical Device Regulation (EU MDR) has created significant challenges for manufacturers, particularly regarding certification timelines. A substantial backlog at Notified Bodies means many devices are struggling to obtain or renew their certificates before deadlines. This situation poses an imminent threat of market withdrawal for numerous products, potentially impacting patient access and company revenues. Businesses need to understand which device categories are most vulnerable to this backlog to prioritize efforts, manage supply chains, and mitigate significant commercial risks.
Who is exposed
Medical device manufacturers face potential revenue loss from products unable to be sold in the EU, and increased costs for navigating the certification process. Regulatory consultants are in high demand, but also face pressure to deliver solutions. Distributors could experience supply chain disruptions and product availability issues. The entire medical device supply chain in Europe is under strain, impacting patient access to essential devices.
Most relevant for: Regulatory Affairs Director, Head of Compliance, Product Portfolio Manager
What this Viewpoint covers
- Which specific medical device classifications or types are experiencing the longest certification delays?
- What are the common reasons for delays in the Notified Body review process?
- How might the backlog disproportionately affect small and medium-sized enterprises?
- Which types of devices are most likely to face market withdrawal due to expiring certificates?
- What strategies are manufacturers employing to navigate the certification bottleneck?
Signals to watch
- Statements from Notified Bodies regarding their capacity and processing times.
- Reports from industry associations on member experiences with MDR certification.
- Public announcements from regulatory authorities on potential deadline extensions or flexibilities.
- Changes in investment or M&A activity related to EU-marketed medical devices.
Decisions it supports
- Prioritizing certification efforts for high-risk device portfolios.
- Developing contingency plans for potential market withdrawal of certain products.
- Adjusting R&D and market entry strategies for new devices in the EU.
How it is built
Prepared after your order from dated public sources - such as medical devices & healthcare filings and announcements, regulatory records, trials, patents and trade data, where relevant - and our market model. Reported facts are cited, estimates are labelled and our assessment is marked as such, following our research method. You receive our verdict, the evidence, who is exposed, the signals to watch and recommended actions, within 24 hours.
Questions
Why is the EU MDR certification backlog a pressing issue?
The backlog threatens the availability of many medical devices in the EU market, leading to potential product withdrawals and supply chain disruptions. Understanding which devices are most affected helps you prioritize your regulatory efforts and mitigate significant commercial risks.
What kind of data does this Viewpoint use to assess risk?
We analyze public information from regulatory bodies, Notified Body announcements, and industry reports on the status of MDR certification. This allows us to identify patterns and specific device categories facing the greatest challenges and delays.
How can this brief help my company manage its EU market strategy?
By highlighting the most vulnerable device categories, this brief helps you allocate resources effectively for certification. It supports strategic decisions on product portfolio management, market access planning, and communication with Notified Bodies to ensure continued EU market presence.